To all our CKB CORE users, don’t miss the latest new features now available! Register for a free CORE account here and then login for access. Feel free to contact us at ckbsupport@genomenon.com if you have any questions!

Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT03340129
Title Anti-PD 1 Brain Collaboration + Radiotherapy Extension (ABC-X Study) (ABC-X)
Acronym ABC-X
Recruitment Recruiting
Gender both
Phase Phase II
Variant Requirements No
Sponsors Melanoma Institute Australia
Indications
Therapies
Age Groups: adult | senior
Covered Countries SWE | NOR | AUS

Facility Status City State Zip Country Details
Westmead Hospital RECRUITING Sydney New South Wales 2145 Australia Details
Calvary Mater NewcastleHospital RECRUITING Waratah New South Wales 2298 Australia Details
Melanoma Institute Australia RECRUITING Wollstonecraft New South Wales 2065 Australia Details
Princess Alexandra Hospital RECRUITING Woolloongabba Queensland 4102 Australia Details
Royal Adelaide Hospital RECRUITING Adelaide South Australia 5000 Australia Details
Peter MacCallum Cancer Centre RECRUITING East Melbourne Victoria 3002 Australia Details
Alfred Hospital RECRUITING Melbourne Victoria 3004 Australia Details
Sir Charles Gairdner Hosptial RECRUITING Perth Western Australia 6009 Australia Details
Oslo Univesity Hospital Radiumhospitalet RECRUITING Oslo 0379 Norway Details
Skåne University Hospital NOT_YET_RECRUITING Lund Skane Sweden Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field